Hematology and Oncology. Lichtman MA, Adamson JW, Lessin LS, Marder VJ, Wiernik PH, ed. New York, Grune and Stratton, The Science and Practice of Clinical Medicine, Vol. 6, 341 pp., 1980.. Unique Identifier : AIDSLINE ICDB/80683953
Winkelstein A; Dept. Medicine, Montefiore Hosp., Pittsburgh, PA
Causes of lymphopenia include glucocorticoid therapy, congenital and acquired immune deficiency diseases, chronic infections, neoplasia, connective tissue diseases, and cytotoxic therapy. Causes of lymphocytosis include mononucleosis, pertussis, and lymphocytic malignancies. Although lymphopenia occurs in a dose-depen
N Engl J Med. 1980 Oct 9;303(15):833-41. Unique Identifier : AIDSLINE MED/81011914
Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
We assessed the efficacy of an inactivated hepatitis B vaccine in a placebo-controlled, randomized, double-blind trial in 1083 homosexual men known to be at high risk for hepatitis B virus infection. The vaccine was found to be safe and the incidence of side effects was low. Within two months, 77% of the vaccinated pe
Simian sarcoma virus type I (SSV-I/SSAV-I) induced syncytia formation in human cells derived from malignant tumors (KB, HEp-2 and HeLa cells) and human cells transformed by tumor viruses (RSa, RSb and KC cells) as well as rat XC cells. However, SSV-I/SSAV-I did not induce syncytia formation in human cells derived from
This information is designed to support, not replace, the relationship that exists between you and your doctor.